Exelixis reported $2.49B in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Akebia Therapeutics AKBA:US USD 13.85M 48.45M
Amgen AMGN:US USD 3.65B 1.23B
AstraZeneca AZN:LN USD 35.13B 798M
Bayer BAYN:GR EUR 41.27B 3.25B
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Cytokinetics CYTK:US USD -15977000 127.39M
Eisai 4523:JP JPY 828.13B 23.58B
Eli Lilly And LLY:US USD 10.07B 1.53B
Esperion Therapeutics ESPR:US USD -294100000 2.4M
Exelixis EXEL:US USD 2.49B 100.14M
Genmab GEN:DC DKK 26.66B 2.18B
Glaxosmithkline GSK:US GBP 9.15B 7.22B
Immunogen IMGN:US USD 178.01M 71.82M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
Macrogenics MGNX:US USD 122.96M 19.52M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Moderna Inc MRNA:US USD 17.99B 7M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Novartis NOVN:VX USD 60.82B 2.1B
Puma Biotechnology PBYI:US USD 22.15M 2.42M
Seattle Genetics SGEN:US USD 2.82B 111M
Takeda 4502:JP JPY 6.71T 396.1B
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Xencor XNCR:US USD 722.7M 19.64M
YTE INCY:US USD 4.23B 141.59M